Edition:
India

Illumina Inc (ILMN.OQ)

ILMN.OQ on NASDAQ Stock Exchange Global Select Market

282.65USD
22 Jun 2018
Change (% chg)

$-3.40 (-1.19%)
Prev Close
$286.05
Open
$286.90
Day's High
$286.90
Day's Low
$282.46
Volume
1,453,163
Avg. Vol
317,459
52-wk High
$292.71
52-wk Low
$168.00

Latest Key Developments (Source: Significant Developments)

Illumina Acquires Edico Genome To Accelerate Genomic Data Analysis
Tuesday, 15 May 2018 

May 15 (Reuters) - Illumina Inc ::ILLUMINA ACQUIRES EDICO GENOME TO ACCELERATE GENOMIC DATA ANALYSIS.  Full Article

Bristol-Myers Squibb And Illumina Announce Collaboration To Develop Companion Diagnostics For Bristol-Myers Squibb's Oncology Immunotherapies
Saturday, 14 Apr 2018 

April 13 (Reuters) - Bristol-Myers Squibb Co ::BRISTOL-MYERS SQUIBB AND ILLUMINA ANNOUNCE STRATEGIC COLLABORATION TO DEVELOP AND COMMERCIALIZE COMPANION DIAGNOSTICS FOR BRISTOL-MYERS SQUIBB’S ONCOLOGY IMMUNOTHERAPIES.EXPANDS ILLUMINA'S ONCOLOGY OFFERINGS FOR NEXTSEQ 550DX.COS PLAN TO DEVELOP A DIAGNOSTIC VERSION OF ILLUMINA TRUSIGHT ONCOLOGY 500 ASSAY TO MEASURE POTENTIALLY PREDICTIVE GENOMIC BIOMARKERS.  Full Article

Loxo Oncology And Illumina To Partner On Developing Pan Cancer Companion Diagnostics
Tuesday, 10 Apr 2018 

April 10 (Reuters) - Loxo Oncology::LOXO ONCOLOGY AND ILLUMINA TO PARTNER ON DEVELOPING NEXT-GENERATION SEQUENCING-BASED PAN-CANCER COMPANION DIAGNOSTICS.LOXO ONCOLOGY-PARTNERSHIP TO SEEK APPROVAL FOR VERSION OF ILLUMINA TRUSIGHT TUMOR 170 AS COMPANION DIAGNOSTIC FOR LAROTRECTINIB, LOXO-292 ACROSS TUMORS .LOXO ONCOLOGY - COMPANIES ALSO PLANNING TO BROADEN CLINICAL UTILITY OF FULL PANEL BY OBTAINING REGULATORY APPROVAL FOR OTHER ASSAY CONTENT.  Full Article

Illumina Sees Non-GAAP Diluted EPS Attributable To Illumina Stockholders In Range Of $4.50-$4.60 For Fiscal Year 2018
Thursday, 11 Jan 2018 

Jan 11 (Reuters) - Illumina Inc ::ILLUMINA INC - SEES NON-GAAP DILUTED EPS ATTRIBUTABLE TO ILLUMINA STOCKHOLDERS IN RANGE OF $4.50 - $4.60 FOR FISCAL YEAR 2018.ILLUMINA - SEES SEES GAAP DILUTED EPS ATTRIBUTABLE TO ILLUMINA STOCKHOLDERS IN RANGE OF $4.14 - $4.24 FOR FISCAL YEAR 2018- SEC FILING.  Full Article

HTG Molecular, Illumina Agreed To Third Development Plan Under Parties' Amended & Restated Development & Supply Agreement
Thursday, 28 Dec 2017 

Dec 27 (Reuters) - HTG Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS - ON DEC 23, CO, ILLUMINA AGREED TO THIRD DEVELOPMENT PLAN UNDER PARTIES' AMENDED & RESTATED DEVELOPMENT & SUPPLY AGREEMENT.HTG MOLECULAR DIAGNOSTICS SAYS UNDER PLAN, ILLUMINA EXPECTED TO DEVELOP & DELIVER TO CO EXECUTABLE VERSION OF CUSTOM SOFTWARE - SEC FILING.  Full Article

Luna Dna Announces $2 Mln In Seed Funding Round Included Several Individual Investors And Former Executives From Illumina
Tuesday, 19 Dec 2017 

Dec 18 (Reuters) - Illumina Inc ::LUNA DNA ANNOUNCES $2 MILLION IN SEED FUNDING; ROUND INCLUDED SEVERAL INDIVIDUAL INVESTORS AND FORMER EXECUTIVES FROM ILLUMINA.  Full Article

Disney Board Elects Oracle And Illumina CEOs As Directors
Friday, 8 Dec 2017 

Dec 7 (Reuters) - Walt Disney Co ::DISNEY BOARD ELECTS ORACLE’S SAFRA CATZ AND ILLUMINA’S FRANCIS A. DESOUZA AS DIRECTORS.WALT DISNEY CO - ELECTIONS OF CATZ AND DESOUZA ARE EFFECTIVE FEBRUARY 1, 2018.WALT DISNEY CO - ELECTION OF 2 NEW DIRECTORS: SAFRA CATZ, CEO OF ORACLE, AND FRANCIS DESOUZA, CEO OF BIOTECHNOLOGY FIRM ILLUMINA INC.  Full Article

Illumina reports Q3 GAAP earnings per share $1.11
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Illumina Inc :Illumina reports financial results for third quarter of fiscal year 2017.Q3 non-GAAP earnings per share $1.11.Q3 GAAP earnings per share $1.11.Q3 revenue $714 million versus I/B/E/S view $692.8 million.Sees fy 2017 non-GAAP earnings per share $3.73 to $3.78.Sees fy 2017 revenue up about 13 percent.Q3 earnings per share view $0.99 -- Thomson Reuters I/B/E/S.Illumina Inc - ‍for fiscal 2017 company now projects GAAP earnings per diluted share attributable to Illumina stockholders of $5.56 to $5.61​.Fy2017 earnings per share view $3.65, revenue view $2.68 billion -- Thomson Reuters I/B/E/S.  Full Article

Illumina increases size of board from eight to nine members
Friday, 29 Jul 2016 

Illumina Inc : Effective as of july 27, 2016, board of directors increased size of board from eight to nine members - sec filing Further company coverage: [ILMN.O] (Bengaluru Newsroom: +1-646-223-8780).  Full Article

Illumina reports Q2 adj. earnings $0.86/shr
Wednesday, 27 Jul 2016 

Illumina Inc : Illumina reports financial results for second quarter of fiscal year 2016 . Q2 non-GAAP earnings per share $0.86 . Q2 GAAP earnings per share $0.82 . Sees Q3 2016 revenue $625 million to $630 million . Q2 revenue $600 million versus I/B/E/S view $593.1 million . Sees FY 2016 non-GAAP earnings per share $3.48 to $3.58 . Sees FY 2016 revenue up about 12 percent .Q2 earnings per share view $0.73 -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Illumina Acquires Edico Genome To Accelerate Genomic Data Analysis

* ILLUMINA ACQUIRES EDICO GENOME TO ACCELERATE GENOMIC DATA ANALYSIS Source text for Eikon: Further company coverage: